Key figures on established biotech centers worldwide 2012-2016

* Aggregate financial performance of publicly traded biotechnology companies in the four established clusters — the United States, Europe, Canada and Australia. Financials largely represent data from 1 January through 31 December. Numbers may appear inconsistent because of rounding. Figures for 2012-2014 were added from previous editions of the report and may not have been be restated.
** 2015-2016 values exclude Australia and Canada.